Results 161 to 170 of about 701,063 (234)

薬物生理学薬品生理学研究室 [PDF]

, 2001
赤尾 光昭, 酒井 秀紀
core   +3 more sources

P23-083-23 Ganoderic Acid A Ameliorates Endothelial Dysfunction in Estrogen-deficient Mice

Current Developments in Nutrition, 2023
openaire   +1 more source

Medicinal Values of Selected Mushrooms with Special Reference to Anti-Hypercholesterolemia [PDF]

, 2015
Keong, Choong Yew
core   +2 more sources

Ganoderic acid A is the effective ingredient of Ganoderma triterpenes in retarding renal cyst development in polycystic kidney disease. [PDF]

Acta Pharmacol Sin, 2020
Meng J, Sai-Zhen Wang, He JZ, Zhu S, Huang BY, Wang SY, Li M, Zhou H, Lin SQ, Yang BX.   +9 more
europepmc   +1 more source

薬物代謝工学 [PDF]

, 2001
中村 憲夫, 宮代 博継, 服部 征雄, 横澤 隆子   +3 more
core   +3 more sources

病態生化学 [PDF]

, 1984
中島 松一, 丸山 由紀子, 林 和子, 荻田 善一   +3 more
core   +5 more sources

Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma. [PDF]

Drug Deliv, 2019
Rahman M, Al-Ghamdi SA, Alharbi KS, Beg S, Sharma K, Anwar F, Al-Abbasi FA, Kumar V.   +7 more
europepmc   +1 more source

Ganoderic acid A ameliorates renal fibrosis by suppressing the expression of NPC1L1

Biocell (Mendoza)
Tianyun Han, Zhong Li, Luoning Zhang, Linshen Xie   +3 more
semanticscholar   +1 more source

薬効解析センター [PDF]

, 2002
Ahmad Javed, Meselhy Meselhy Ragab, 小松 かつ子, 東田 千尋, 谿 忠人   +4 more
core   +1 more source

Ganoderic Acid A Alleviates High‐Fat Diet‐Induced Lipid Metabolism Disorders in Mice by Inhibiting Intestinal Farnesoid X Receptor

Food Frontiers, Volume 6, Issue 6, Page 3108-3121, November 2025.
Lipid metabolism disorders (LMDs) can cause many metabolic diseases and seriously threaten human health. It is necessary to develop safe drugs for long‐term use in LMDs patients. Ganoderma lucidum (G.
Feng Lu, Shanshan Ju, Yi Ying, Jihan Liu, Chengfeng Yang, Min Li, Hong Zhou, Baoxue Yang   +7 more
semanticscholar   +2 more sources